Evidence map›Paper›PMID 31293429›Full record

ReviewFrontiers in pharmacology2019

Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.

Ryan D Jones, Jie Liao, Xin Tong, Dandan Xu, Leyu Sun, Haonan Li, Guang-Yu Yang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ryan D JonesDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Jie LiaoDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Xin TongDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Dandan XuDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Leyu SunDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Haonan LiDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Guang-Yu YangDepartment of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Northwestern University · US

Funding

Omega-3 derived epoxy fatty acids and sEH in pancreatitis-induced carcinogenesisR01DK107767 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI YANG, GUANG-YU · 2016 to 2019
$1.9M
Inhibition of pancreatic carcinogenesis via targeting c-Raf and sEHR01CA172431 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI YANG, GUANG-YU · 2013 to 2017
$1.6M
Soluble epoxide hydrolase as a novel target of colitis-induced carcinogenesisR01CA137467 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI YANG, GUANG-YU · 2009 to 2012
$1.2M
Ulcerative colitis-associated cancer and its preventionR01CA104741 · NCI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YANG, GUANG-YU · 2004 to 2008
$1.2M
NCI NIH HHS R01 CA104741NCI NIH HHS R01 CA137467NCI NIH HHS R01 CA172431NIDDK NIH HHS R01 DK107767
6 · The paper itself

Abstract

Polyunsaturated fatty acids (PUFAs) including epoxide-modified ω-3 and ω-6 fatty acids are made

Indexed as

carcinogenesisinflammationnon-steroidal anti-inflammatory drugoxylipinsoluble epoxide hydrolase

Identifiers

PMID31293429
PMCPMC6603234
OpenAlexW2953683128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.